Skip to main content
. 2022 Jun 10;32(6):613–639. doi: 10.1089/thy.2021.0666

Table 3.

Quality Assessment

Study, year Consecutive or random sample Blinding of outcomes assessment to Tg test Low attrition or missing data Appropriate reference standard Same reference standard in all patients Prespecified Tg threshold Timing of Tg testing and assessment of outcomes reported Quality Other limitations
Tg testing following partial thyroidectomy
 Alzahrani, 2002 (7) Unclear No Unclear Yes Yes Yes No (Tg testing) Fair  
 Park, 2018 (30) Unclear No No Yes Yes No Yes Poor  
 Ritter, 2020 (33) Unclear No Unclear Unclear Unclear Unclear Yes Poor  
 Vaisman, 2013 (39) Yes No Unclear Yes Yes Unclear Yes Fair Minor data discrepancya
Tg testing following total or near-total thyroidectomy without RAI therapy
 Durante, 2012 (9) Yes No Unclear Yes Unclear Yes Unclear (Tg testing and follow-up duration) Fair  
 Janovsky, 2016 (14) Yes No Unclear Yes Yes Yes Yes Fair  
 Matrone, 2020 (24) Yes No Unclear Yes Unclear Unclear Unclear (Tg testing and follow-up duration) Poor  
 Nascimento, 2013 (27) Yes No Unclear Yes Unclear Unclear Yes Poor  
 van Wyngaarden, 1997 (40) Unclear No Unclear Unclear Unclear Not applicable Unclear (Tg testing) Poor  
Postoperative thyroglobulin testing before RAI therapy
 Caballero-Calabuig, 2008 (8) Yes No Yes No Yes No Yes Fair  
 Giovanella, 2008 (10) Yes No Unclear No Yes No Yes Fair  
 Grunwald, 1996 (11) Unclear No Unclear No Yes No Yes Poor  
 Hasbek, 2014 (12) Yes No Unclear No Yes No No (Tg testing) Poor  
 Heemstra, 2007 (13) Yes No Unclear Unclear Unclear No No (Tg testing) Poor 82 patients with anti-TgAb excluded
 Kim, 2013 (15) Yes No Unclear Yes Unclear No No (Tg testing) Poor  
 Kim, 2005 (16) Yes No Unclear Yes Yes No Yes Fair  
 Krajewska, 2016 (17) Yes No Unclear Yes Yes Yes No (Tg testing) Fair Data discrepancy presentb
 Latrofa, 2016 (18) Yes No Unclear Yes Yes Unclear Yes Fair  
 Ledwon, 2021 (19) Unclear No Unclear Yes No No Yes Poor  
 Lima, 2002 (20) Unclear No Unclear Unclear Yes No Yes Poor Data discrepancy presentb
 Lin, 2011 (21) Unclear No Unclear Yes Yes Unclear Yes Poor  
 Makarewicz, 2006 (22) Unclear No Unclear Yes Yes Not applicable Yes Poor  
 Makarewicz, 2006 (23) Unclear No Unclear Yes Yes No No (Tg testing and follow-up duration) Poor  
 Matrone, 2017 (25) Yes No Unclear Yes Yes No Yes Fair  
 Matthews, 2016 (26) Yes No No Unclear Unclear No No (Tg testing and follow-up duration) Poor  
 Ng, 2000 (28) Unclear No Unclear No No Yes No (Tg testing) Poor  
 Oyen, 2000 (29) Unclear No Yes Unclear No Yes No Poor  
 Polachek, 2011 (31) Yes No Unclear Yes No No No (Tg testing) Poor  
 Prabhu, 2018 (43) Unclear Unclear Unclear No Yes No Yes Poor  
 Ren, 2021 (32) Unclear No Unclear Yes No No No (Tg testing) Poor  
 Ronga, 1999 (34) Yes No Unclear Yes Yes No No (follow-up duration) Poor  
 Rosario, 2011 (35) Yes No Unclear Yes Yes No Yes Fair  
 Szujo, 2021 (36) Unclear No No Unclear Unclear No No (Tg testing) Poor Data discrepancy presentb
 Torlantano, 2006 (37) Yes No Unclear Unclear Yes Unclear Yes Poor  
 Toubeau, 2004 (38) Yes No No Yes Unclear Unclear Yes Poor  
 Zerva, 2006 (41) Unclear No Unclear No Yes No No (Tg testing) Poor  
 Zhao, 2017 (42) Yes No Unclear Yes Yes No No (Tg testing and follow-up duration) Poor Cutoffs for change in Tg and change in Tg/change in TSH unclear
a

Study reports 14 false-positive patients, which would result in specificity of 0.78 (51/65) rather than 0.80 as reported in study.

b

Discrepancy between reported diagnostic accuracy and data reported in study; diagnostic accuracy calculated from data in study.